These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25754317)

  • 1. Metabolic Dysfunction in Pulmonary Arterial Hypertension.
    Assad TR; Hemnes AR
    Curr Hypertens Rep; 2015 Mar; 17(3):20. PubMed ID: 25754317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension.
    Ryan JJ; Archer SL
    Circulation; 2015 May; 131(19):1691-702. PubMed ID: 25964279
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man.
    Pugh ME; Hemnes AR
    Int J Clin Pract Suppl; 2010 Nov; 64(168):5-13. PubMed ID: 20939841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism in Pulmonary Hypertension.
    Xu W; Janocha AJ; Erzurum SC
    Annu Rev Physiol; 2021 Feb; 83():551-576. PubMed ID: 33566674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.
    Plecitá-Hlavatá L; D'alessandro A; El Kasmi K; Li M; Zhang H; Ježek P; Stenmark KR
    Adv Exp Med Biol; 2017; 967():241-260. PubMed ID: 29047090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension.
    Sutendra G; Bonnet S; Rochefort G; Haromy A; Folmes KD; Lopaschuk GD; Dyck JR; Michelakis ED
    Sci Transl Med; 2010 Aug; 2(44):44ra58. PubMed ID: 20702857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response.
    Ohira H; deKemp R; Pena E; Davies RA; Stewart DJ; Chandy G; Contreras-Dominguez V; Dennie C; Mc Ardle B; Mc Klein R; Renaud JM; DaSilva JN; Pugliese C; Dunne R; Beanlands R; Mielniczuk LM
    Eur Heart J Cardiovasc Imaging; 2016 Dec; 17(12):1424-1431. PubMed ID: 26060207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains.
    Culley MK; Chan SY
    J Clin Invest; 2018 Aug; 128(9):3704-3715. PubMed ID: 30080181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative and nitrosative signalling in pulmonary arterial hypertension - Implications for development of novel therapies.
    Hansen T; Galougahi KK; Celermajer D; Rasko N; Tang O; Bubb KJ; Figtree G
    Pharmacol Ther; 2016 Sep; 165():50-62. PubMed ID: 27216365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis and current pathology of pulmonary hypertension.
    de Jesus Perez VA
    Heart Fail Rev; 2016 May; 21(3):239-57. PubMed ID: 26694808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology and pathobiology of pulmonary hypertension.
    Guignabert C; Dorfmuller P
    Semin Respir Crit Care Med; 2013 Oct; 34(5):551-9. PubMed ID: 24037624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect.
    Cottrill KA; Chan SY
    Eur J Clin Invest; 2013 Aug; 43(8):855-65. PubMed ID: 23617881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Right Heart-Pulmonary Circulation Unit in Systemic Hypertension.
    Vriz O; Motoji Y; Ferrara F; Bossone E; Naeije R
    Heart Fail Clin; 2018 Jul; 14(3):247-253. PubMed ID: 29966624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives.
    Guazzi M; Naeije R
    J Am Coll Cardiol; 2017 Apr; 69(13):1718-1734. PubMed ID: 28359519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension.
    Lewis GD; Ngo D; Hemnes AR; Farrell L; Domos C; Pappagianopoulos PP; Dhakal BP; Souza A; Shi X; Pugh ME; Beloiartsev A; Sinha S; Clish CB; Gerszten RE
    J Am Coll Cardiol; 2016 Jan; 67(2):174-189. PubMed ID: 26791065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic theory of pulmonary arterial hypertension.
    Paulin R; Michelakis ED
    Circ Res; 2014 Jun; 115(1):148-64. PubMed ID: 24951764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria: roles in pulmonary hypertension.
    Freund-Michel V; Khoyrattee N; Savineau JP; Muller B; Guibert C
    Int J Biochem Cell Biol; 2014 Oct; 55():93-7. PubMed ID: 25149415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.
    Vonk-Noordegraaf A; Haddad F; Chin KM; Forfia PR; Kawut SM; Lumens J; Naeije R; Newman J; Oudiz RJ; Provencher S; Torbicki A; Voelkel NF; Hassoun PM
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D22-33. PubMed ID: 24355638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary arterial hypertension in intensive care unit and operating room].
    Kerbaul F; Rondelet B; Collart F; Naeije R; Gouin F
    Ann Fr Anesth Reanim; 2005 May; 24(5):528-40. PubMed ID: 15904732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
    Hong Z; Chen KH; DasGupta A; Potus F; Dunham-Snary K; Bonnet S; Tian L; Fu J; Breuils-Bonnet S; Provencher S; Wu D; Mewburn J; Ormiston ML; Archer SL
    Am J Respir Crit Care Med; 2017 Feb; 195(4):515-529. PubMed ID: 27648837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.